Evolent Health, Inc. (EVH) P/B ratio

P/B ratio today
1.3×

Evolent Health, Inc. (EVH) trades at 1.3× its book value per share at the end of fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/B ratio was 1.1×. That is 14.6% lower than the 1.3× of fiscal 2024. Figures as of 18 Nov 2026, 07:11 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/B ratio today
1.3×
P/B ratio, fiscal 2025
1.1×
Change on fiscal 2024
−14.6%
Highest on record
3.4×fiscal 2023
Lowest on record
0.8×fiscal 2017
Fiscal years on record
102015–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Evolent Health, Inc. P/B ratio, in more detail

Today's figure is 15.5% above the fiscal 2025 year-end.

Across the 10 fiscal year-ends on record (2015–2025), the highest was 3.4× in fiscal 2023 and the lowest 0.8× in fiscal 2017. Today's P/B ratio is higher than at 50% of the 10 fiscal year-ends on record; their median is 1.2×.

History · 10 fiscal years

P/B ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Evolent Health, Inc. P/B ratio, year by year

Evolent Health, Inc. (EVH) P/B ratio by fiscal year
Fiscal yearP/B ratioChangeYear endedShare price at year-endBook value per share
Today1.3×—$4.62—
20251.1× 14.6% down$4.00$3.64
20241.3× 62.6% down$11.25$8.73
20233.4× 12.4% up$33.03$9.60
20223.1× 10.8% down$28.08$9.17
20213.4× 56.3% up$27.67$8.06
20202.2× 173.9% up$16.03$7.30
20190.8×—$9.05$11.28
2018——$19.95—
20170.8× 17.5% down$12.30$15.71
20160.9× 10.3% up$14.80$15.60
20150.9×—$12.11$14.07
2014———-$0.89
2013———$4.44

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/B ratio is the share price divided by book value per share — shareholders' equity on the balance sheet divided by the share count — at each fiscal year-end; a year with negative equity has no P/B.

How to read it

It compares the price with the accounting value of what the company owns net of what it owes, and matters most for banks, insurers and other balance-sheet businesses.

More on EVH

Evolent Health, Inc., figure by figure

Evolent Health, Inc. (EVH) overview: price, valuation and scorecard

Evolent Health, Inc. P/B ratio: questions and answers

What is Evolent Health, Inc.'s P/B ratio?

Evolent Health, Inc. (EVH) trades at 1.3× its book value per share at the end of fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/B ratio was 1.1×. That is 14.6% lower than the 1.3× of fiscal 2024.

Is Evolent Health, Inc.'s P/B ratio high or low compared with its own history?

Today's P/B ratio is higher than at 50% of the 10 fiscal year-ends on record; their median is 1.2×.

What are the highest and lowest P/B ratio figures on record for Evolent Health, Inc.?

Across the 10 fiscal year-ends on record (2015–2025), the highest was 3.4× in fiscal 2023 and the lowest 0.8× in fiscal 2017.

How is Evolent Health, Inc.'s P/B ratio calculated?

The P/B ratio is the share price divided by book value per share — shareholders' equity on the balance sheet divided by the share count — at each fiscal year-end; a year with negative equity has no P/B.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Evolent Health, Inc. (EVH) P/B ratio”, data as of 18 November 2026. https://funkfolio.com/stock/EVH/pb-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.